RPRX logo

Royalty Pharma (RPRX) Revenue

Annual Revenue

$2.35 B
+$117.34 M+5.24%

31 December 2023

RPRX Revenue Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Revenue

$564.69 M
+$27.42 M+5.10%

30 September 2024

RPRX Quarterly Revenue Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM Revenue

$2.27 B
+$28.38 M+1.27%

30 September 2024

RPRX TTM Revenue Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

RPRX Revenue Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+5.2%+5.3%-2.5%
3 y3 years+10.9%-3.6%-0.9%
5 y5 years+31.2%+21.6%+67.0%

RPRX Revenue High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 yearsat high+10.9%-17.4%+5.4%-4.0%+1.3%
5 y5 yearsat high+31.2%-17.4%+23.4%-4.0%+67.0%
alltimeall timeat high+47.4%-17.4%+29.9%-4.0%+421.1%

Royalty Pharma Revenue History

DateAnnualQuarterlyTTM
Sept 2024
-
$564.69 M(+5.1%)
$2.27 B(+1.3%)
June 2024
-
$537.27 M(-5.4%)
$2.24 B(-0.0%)
Mar 2024
-
$567.98 M(-4.7%)
$2.24 B(-4.9%)
Dec 2023
$2.35 B(+5.2%)
$596.07 M(+11.1%)
$2.35 B(+1.3%)
Sept 2023
-
$536.31 M(-0.4%)
$2.32 B(-1.6%)
June 2023
-
$538.20 M(-21.3%)
$2.36 B(+0.1%)
Mar 2023
-
$683.97 M(+20.9%)
$2.36 B(+5.4%)
Dec 2022
$2.24 B(-2.3%)
$565.75 M(-1.3%)
$2.24 B(-0.4%)
Sept 2022
-
$573.46 M(+7.0%)
$2.25 B(-0.5%)
June 2022
-
$535.96 M(-4.6%)
$2.26 B(-0.8%)
Mar 2022
-
$562.05 M(-2.4%)
$2.28 B(-0.5%)
Dec 2021
$2.29 B
$575.70 M(-1.7%)
$2.29 B(+0.2%)
DateAnnualQuarterlyTTM
Sept 2021
-
$585.77 M(+5.6%)
$2.29 B(+2.1%)
June 2021
-
$554.96 M(-3.2%)
$2.24 B(+2.0%)
Mar 2021
-
$573.03 M(+0.2%)
$2.19 B(+3.4%)
Dec 2020
$2.12 B(+17.0%)
$572.14 M(+6.3%)
$2.12 B(+5.7%)
Sept 2020
-
$538.40 M(+5.4%)
$2.01 B(+3.8%)
June 2020
-
$510.93 M(+2.0%)
$1.93 B(+2.8%)
Mar 2020
-
$500.88 M(+9.5%)
$1.88 B(+3.6%)
Dec 2019
$1.81 B(+1.1%)
$457.49 M(-1.5%)
$1.81 B(+33.7%)
Sept 2019
-
$464.28 M(+1.5%)
$1.36 B(+52.0%)
June 2019
-
$457.61 M(+5.2%)
$892.49 M(+105.2%)
Mar 2019
-
$434.88 M
$434.88 M
Dec 2018
$1.79 B(+12.3%)
-
-
Dec 2017
$1.60 B
-
-

FAQ

  • What is Royalty Pharma annual revenue?
  • What is the all time high annual revenue for Royalty Pharma?
  • What is Royalty Pharma annual revenue year-on-year change?
  • What is Royalty Pharma quarterly revenue?
  • What is the all time high quarterly revenue for Royalty Pharma?
  • What is Royalty Pharma quarterly revenue year-on-year change?
  • What is Royalty Pharma TTM revenue?
  • What is the all time high TTM revenue for Royalty Pharma?
  • What is Royalty Pharma TTM revenue year-on-year change?

What is Royalty Pharma annual revenue?

The current annual revenue of RPRX is $2.35 B

What is the all time high annual revenue for Royalty Pharma?

Royalty Pharma all-time high annual revenue is $2.35 B

What is Royalty Pharma annual revenue year-on-year change?

Over the past year, RPRX annual revenue has changed by +$117.34 M (+5.24%)

What is Royalty Pharma quarterly revenue?

The current quarterly revenue of RPRX is $564.69 M

What is the all time high quarterly revenue for Royalty Pharma?

Royalty Pharma all-time high quarterly revenue is $683.97 M

What is Royalty Pharma quarterly revenue year-on-year change?

Over the past year, RPRX quarterly revenue has changed by +$28.38 M (+5.29%)

What is Royalty Pharma TTM revenue?

The current TTM revenue of RPRX is $2.27 B

What is the all time high TTM revenue for Royalty Pharma?

Royalty Pharma all-time high TTM revenue is $2.36 B

What is Royalty Pharma TTM revenue year-on-year change?

Over the past year, RPRX TTM revenue has changed by -$58.23 M (-2.51%)